Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA polyadenylation is a post-transcriptional modification process involving the addition of a poly(A) tail (a string of adenine nucleotides) to the 3' end of RNA molecules, primarily mRNA. This process is crucial for mRNA stability, nuclear export, translation efficiency, and regulation of gene expression. In eukaryotes, it is essential for mRNA maturation, while in prokaryotes, it typically marks RNAs for degradation. The process is catalyzed by poly(A) polymerase (PAP) and involves various cleavage and polyadenylation factors.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA Polyadenylation (Poly(A)).